Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
Clinical trial NCT00088582 · COMPLETED
Trial details
- NCT number
- NCT00088582
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2005-10-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.